Medical Devices industry deals total $7.09bn globally in March 2021

Total medical devices industry deals worth $7.09bn were announced globally for March 2021, with the $1.07bn asset transaction with Lumenis being the sector’s biggest investment, according to GlobalData’s deals database.

The value marked an increase of 60.4% over the previous month of $4.42bn and a drop of 27.6% when compared with the last 12-month average of $9.79bn.

In terms of number of deals, the sector saw a drop of 4.82% with 158 deals in March 2021 when compared to the last 12-month average of 166 deals.

In value terms, North America led the activity with deals worth $4.89bn in March 2021.

Medical Devices industry deals in March 2021: Top deals

The top five deals accounted for 50.2% of the overall value during March 2021.

The combined value of the top five deals stood at $3.56bn, against the overall value of $7.09bn recorded for the month.

The top five medical devices industry deals of March 2021 tracked by GlobalData were:

1) Boston Scientific’s $1.07bn asset transaction with Lumenis

2) The $1bn private equity deal with Cardinal Health by Hellman & Friedman

3) Agilent Technologies’ $695m acquisition of Resolution Bioscience

4) The $475m acquisition deal of Northfield Medical by Agiliti

5) Bio Techne’s acquisition deal with Asuragen for $320m.